More understanding of the precise intracellular mechanisms downstream of PI3K/AKT/PTEN/GSK3/mTOR signaling changes in NAFLD could provide novel insights into the development of new therapeutic approaches having greater efficacy against NAFLD. Here, PIK3CD is linked to metabolic dysfunction-associated steatotic liver disease.